The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma.
Okamoto I, Roka F, Krögler J, Endler G, Kaufmann S, Tockner S, Marsik C, Jilma B, Mannhalter C, Wagner O, Pehamberger H.
Okamoto I, et al. Among authors: roka f.
J Invest Dermatol. 2006 Oct;126(10):2242-6. doi: 10.1038/sj.jid.5700377. Epub 2006 May 11.
J Invest Dermatol. 2006.
PMID: 16691190
Free article.